| Literature DB >> 26047667 |
Sara Crespo Yanguas1, Bruno Cogliati2, Joost Willebrords1, Michaël Maes1, Isabelle Colle3, Bert van den Bossche4, Claudia Pinto Marques Souza de Oliveira5, Wellington Andraus6, Venâncio Avancini Ferreira Alves7, Isabelle Leclercq8, Mathieu Vinken1.
Abstract
Hepatic fibrosis is a wound healing response to insults and as such affects the entire world population. In industrialized countries, the main causes of liver fibrosis include alcohol abuse, chronic hepatitis virus infection and non-alcoholic steatohepatitis. A central event in liver fibrosis is the activation of hepatic stellate cells, which is triggered by a plethora of signaling pathways. Liver fibrosis can progress into more severe stages, known as cirrhosis, when liver acini are substituted by nodules, and further to hepatocellular carcinoma. Considerable efforts are currently devoted to liver fibrosis research, not only with the goal of further elucidating the molecular mechanisms that drive this disease, but equally in view of establishing effective diagnostic and therapeutic strategies. The present paper provides a state-of-the-art overview of in vivo and in vitro models used in the field of experimental liver fibrosis research.Entities:
Keywords: Animal models; Hepatic stellate cells; In vitro models; Liver fibrosis
Mesh:
Year: 2015 PMID: 26047667 PMCID: PMC4705434 DOI: 10.1007/s00204-015-1543-4
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 5.153